Financhill
Back

Alaunos Therapeutics Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
20

TCRT
Alaunos Therapeutics

Last Price:
2.00
Seasonality Move:
11.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Alaunos Therapeutics Price Quote

$2.00
-0.01 (-1.96%)
(Updated: November 5, 2024 at 5:44 AM ET)

Alaunos Therapeutics Key Stats

Sell
20
Alaunos Therapeutics (TCRT) is a Sell

Day range:
$2.00 - $2.04
52-week range:
$2.00 - $32.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.85%

Volume:
5.3K
Avg. volume:
19.4K
1-year change:
-82.44%
Market cap:
$3.2M
Revenue:
$5K
EPS:
$-12.71

How Much Does Alaunos Therapeutics Make?

Data Unavailable

Is Alaunos Therapeutics Growing As A Company?

  • What Is Alaunos Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0%
  • What Is Alaunos Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Alaunos Therapeutics Stock Price Performance

What Is Alaunos Therapeutics 52-Week High & Low?

Alaunos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Alaunos Therapeutics?

Is Alaunos Therapeutics Cash Flow Positive?

  • What Is TCRT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.4M
  • What Is Alaunos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Alaunos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1.5M

Alaunos Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TCRT return on invested capital is -189.69%
  • What Is Alaunos Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -144.17%
  • What Is TCRT Return On Equity?
    ROE is a measure of profitability and is -189.69%

Alaunos Therapeutics Earnings Date & Stock Price

Alaunos Therapeutics Competitors

Alaunos Therapeutics Dividend Yield

Alaunos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -279.87%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 205.50
Upside from Last Price: 10127.44%

Major Shareholders

  • How many TCRT shares are owned by institutional investors?
    737.1K TCRT shares are owned by institutional investors
  • How many TCRT shares are owned by insiders?
    0 TCRT shares are owned by insiders